Kezar Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	66.23	71.88	41.75	35.49	40.46	62.88
Short-Term Investments	-	-	90.5	165.88	236.11	145.47
Cash & Short-Term Investments	66.23	71.88	132.25	201.37	276.56	208.36
Cash Growth	-42.09%	-45.65%	-34.33%	-27.19%	32.73%	48.35%
Other Current Assets	1.33	3.85	5.24	5.58	9.16	3.3
Total Current Assets	67.56	75.73	137.49	206.95	285.72	211.65
Net Property, Plant & Equipment	0.44	0.92	4.78	8.69	13.17	6
Other Long-Term Assets	-	-	2.42	5.6	0.67	0.28
Total Assets	68	76.65	144.68	221.24	299.57	217.93
Accounts Payable	0.27	0.51	3.65	8.25	2.48	2.03
Accrued Expenses	1.14	3.74	7.94	6.48	5.95	4.99
Short-Term Debt	-	-	5.22	-	-	-
Current Portion of Leases	1.35	2.33	3.53	3.01	2.57	1.2
Other Current Liabilities	1.14	3.74	7.94	6.48	5.95	4.99
Total Current Liabilities	2.76	6.57	20.33	17.74	11	8.21
Long-Term Debt	-	-	5.11	10.07	9.83	9.62
Long-Term Leases	-	-	2.33	5.85	8.87	3.22
Total Long-Term Liabilities	-	-	7.44	15.92	18.7	12.85
Total Liabilities	2.76	6.57	27.77	33.67	29.7	21.06
Common Stock	0.01	0.01	0.01	0.01	0.07	0.06
Additional Paid-in Capital	561.52	560.6	551.57	538.46	519.62	377.77
Accumulated Other Comprehensive Income	-	-	-0.16	-0.13	-0.92	-0.29
Retained Earnings	-496.29	-490.53	-434.5	-350.76	-248.89	-180.65
Shareholders' Equity	65.24	70.07	116.92	187.57	269.87	196.88
Total Liabilities & Equity	68	76.65	144.68	221.24	299.57	217.93
Total Debt	1.35	2.33	16.18	18.93	21.26	14.04
Net Cash (Debt)	64.88	69.55	116.07	182.44	255.3	194.31
Net Cash Growth	-6.72%	-40.08%	-36.38%	-28.54%	31.39%	43.95%
Net Cash Per Share	8.85	9.51	15.92	25.14	37.90	36.83
Book Value	65.24	70.07	116.92	187.57	269.87	196.88
Book Value Per Share	8.90	9.58	16.04	25.85	40.06	37.32
Tangible Book Value	65.24	70.07	116.92	187.57	269.87	196.88
Tangible Book Value Per Share	8.90	9.58	16.04	25.85	40.06	37.32

SEC Filings: 10-K · 10-Q